Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M682Revenue (TTM) $M44.4Net Margin (%)-88.0Altman Z-Score6.9
Enterprise Value $M547EPS (TTM) $-0.6Operating Margin %-100.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.7Pre-tax Margin (%)-92.7Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %-15.3Quick Ratio4.2Cash flow > EarningsY
Price/Sales15.25-y EBITDA Growth Rate %-5.9Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-22.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.6ROIC % (ttm)-188.5Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOJoel Greenblatt 2016-03-31 Sold Out $4.92 - $8.71
($6.42)
$ 9.4647%Sold Out0
INOJoel Greenblatt 2015-12-31 Buy $5.65 - $7.41
($6.67)
$ 9.4642%New holding37,123
INOFirst Eagle Investment 2014-03-31 Sold Out -0.002%$9.76 - $15.28
($11.96)
$ 9.46-21%Sold Out0
INOFirst Eagle Investment 2013-12-31 Buy $6.92 - $11.88
($8.34)
$ 9.4613%New holding62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COLLINS MORTONDirector 2016-06-28Buy10,000$9.133.61view
BENITO SIMON XDirector 2016-05-18Sell6,250$10.37-8.78view
COLLINS MORTONDirector 2016-04-15Buy68,400$9.52-0.63view
Sardesai NiranjanCOO 2015-09-30Buy4,000$5.572view
BENITO SIMON XDirector 2015-08-14Buy6,000$7.2131.21view
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-0.73view
KIES PETERCFO 2014-10-09Buy3,960$10.1-6.34view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-5.49view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-2.87view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.064.42view

Press Releases about INO :

Quarterly/Annual Reports about INO:

News about INO:

Articles On GuruFocus.com
Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 

More From Other Websites
7:02 am Inovio Pharma initiates a clinical study of its preventive Zika vaccine in 160 subjects in... Aug 29 2016
4 Stocks for Fighting Zika Aug 25 2016
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline Aug 17 2016
INOVIO PHARMACEUTICALS, INC. Financials Aug 16 2016
Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences Aug 16 2016
Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences Aug 16 2016
Inovio Expands Enrollment in Ebola Vaccine Phase I Study Aug 15 2016
ETF’s with exposure to Inovio Pharmaceuticals, Inc. : August 15, 2016 Aug 15 2016
Obama Moves Money Around To Keep Zika Research Going Amid Lack Of Congressional Funds Allocation Aug 12 2016
Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal... Aug 11 2016
Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal... Aug 11 2016
Inovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 Aug 10 2016
[$$] Inovio Pharma May Be Burning Too Hot Aug 10 2016
Inovio (INO) Q2 Loss in Line with Estimates, Revenues Top Aug 09 2016
Inovio Pharma downgraded by Maxim Group Aug 09 2016
GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine Aug 08 2016
Inovio (INO) Stock Slumps After Mixed Q2 Results Aug 08 2016
Inovio (INO) Reports In-Line Loss in Q2, Revenues Beat Aug 08 2016
The Zacks Analyst Blog Highlights: Companhia de Saneamento Basico do Estado de Sao Paulo, Cemig,... Aug 08 2016
Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results Aug 08 2016
Inovio reports 2Q loss Aug 08 2016
Inovio reports 2Q loss Aug 08 2016
Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results Aug 08 2016
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs Aug 04 2016
Inovio will Independently Develop Hepatitis B Immunotherapy Aug 03 2016
Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial Jul 26 2016
Inovio Pharmaceuticals to Report Second Quarter 2016 Financial Results August 8, 2016 Jul 26 2016
Inovio Deploys DNA-based Monoclonal Antibody Technology in Quest to Cure HIV Jul 14 2016
Experimental Zika vaccine to begin human testing Jun 20 2016
Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine... Jun 20 2016
Inovio Pharmaceuticals Zika Vaccine Produces Robust Immune Responses in Non-Human Primates May 16 2016
Inovio Pharmaceuticals to Present at UBS Global Healthcare Conference May 11 2016
Inovio reports 1Q loss May 09 2016
Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results May 09 2016
Inovio Pharmaceuticals Showcases its Broad Pipeline of DNA-based Immunotherapies, Vaccines and dMAbs... May 04 2016
Inovio Pharmaceuticals Completes Acquisition of Needle-Free Injection Technology May 02 2016
Inovio Partners with National Cancer Institute and Mayo Clinic to Initiate Hepatitis C Immunotherapy... Apr 27 2016
Inovio Pharmaceuticals to Report First Quarter 2016 Financial Results May 9, 2016 Apr 26 2016
Inovio Ebola Vaccine Generates Robust Immune Responses in Humans Mar 30 2016
Inovio Pharmaceuticals HPV Immunotherapy Selected as “Best Therapeutic Vaccine” by World Vaccine... Mar 30 2016
Inovio Updates INO-3112 HPV Immunotherapy Development Plan Mar 29 2016
Inovio’s DNA-based Monoclonal Antibody and DNA Vaccine Provide 100% Protection Against Lethal... Mar 22 2016
Inovio reports 4Q loss Mar 14 2016
Sanofi launches hunt for Zika vaccine as disease fears grow Feb 02 2016
Inovio beats 3Q profit forecasts Nov 09 2015
Inovio reports 2Q loss Aug 10 2015
Inovio reports 1Q loss May 11 2015
Inovio posts 3Q loss Nov 10 2014
Ahead of the Bell: Ebola treatment makers rise Oct 01 2014
Shares of companies testing Ebola vaccines rise Sep 30 2014
Inovio Pharma plans humans trials of Ebola vaccine Sep 24 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)